Transient gene expression in suspension HEK-293 cells: Application to large-scale protein production

Biotechnology Progress

Volumn 21, Issue 1, 2005, Pages 148-153

  Baldi, Lucia ^a   Muller, Natalie ^a   Picasso, Sylviane ^a   Jacquet, Raymond ^a   Girard, Philippe ^a   Huy, Phan Thanh ^a   Derow, Elisabeth ^a   Wurm, Florian M ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOREACTORS; CALCIUM; CELL CULTURE; DNA; SUSPENSIONS (FLUIDS);

CALFECTION; PLASMID VECTORS; STRUCTURAL BIOLOGY; TRANSFECTION PROTOCOL;

PROTEINS;

DNA; PROTEIN;

ARTICLE; BIOREACTOR; CELL CULTURE; CELL LINE; CULTURE MEDIUM; CULTURE TECHNIQUE; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PLASMID; SUSPENSION;

BIOREACTORS; CELL CULTURE TECHNIQUES; CELL LINE; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DNA; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; PLASMIDS; PROTEINS; SUSPENSIONS; TRANSFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA; MAMMALIA;

EID: 13544257263     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp049830x     Document Type: Article

References (33)

1. Chu, L.; Robinson, D. K. Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol. 2001, 12 (2), 180-187.
2. Kelley, B. D. Biochemical engineering: Bioprocessing of therapeutic proteins. Curr. Opin. Biotechnol. 2001. 12 (2), p 173-174.
3. Wurm, F.; Bernard, A. Large-scale transient expression in mammalian cells for recombinant protein production. Curr. Opin. Biotechnol. 1999, 10 (2), 156-159.
4. Cho, M.-S.; Yee, H.; Brown, C.; Mei, B.; Mirenda, C.; Chan, S. Versatile expression system for rapid and stable production of recombinant proteins. Biotechnol. Prog. 2003, 19 (1), 229-232.
5. Durocher, Y.; Perret, S.; Kamen, A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002, 30 (2), E9.
6. Meissner, P.; Pick, H.; Kulangara, A.; Chatellard, P.; Friedrich, K.; Wurm, F. M. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol. Bioeng. 2001, 75 (2), 197-203.
7. Schlaeger, E. J.; Christensen, K. Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology 1999, 30, 71-83.
8. Pham, P. L.; Perret, S.; Doan, H. C.; Cass, B.; St-Laurent, G.; Kamen, A.; Durocher, Y. Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol. Bioeng. 2003, 84 (3), 332-342.
9. Jordan, M.; Kohne, C.; Wurm, F. M. Calcium-phosphate mediated DNA transfer into HEK-293 cells in suspension: Control of physicochemical parameters allows transfection in stirred media. Cytotechnology 1998, 26, 39-47.
10. Girard, P.; Derouazi, M.; Baumgartner, G.; Bourgeois, M.; Jordan, M.; Jacko, B.; Wurm, F. M. 100-liter transient transfection. Cytotechnology 2002, 38, 15-21.
11. Derouazi, M.; Girard, P.; Van Tilborgh, F.; Iglesias, K.; Muller, N.; Bertschinger, M.; Wurm, F. M. Serum-free large-scale transient transfection of CHO cells. Biotechnol. Bioeng. 2004, 87 (4), 537-545.
12. Muller, N.; Girard, P.; Hacker, D. L.; Jordan, M.; Wurm, F. Orbital shaking technology for the cultivation of mammalian cells in suspension. Biotechnol. Bioeng. 2004, in press.
13. Girard, P.; L. Porte; T. Berta; Jordan, M.; Wurm, F. M. Calcium phosphate transfection optimization for serum-free suspension culture. Cytotechnology 2001, 35 (3), 175-180.
14. Pick, H. M.; Meissner, P.; Preuss, A. K.; Tromba, P.; Vogel, H.; Wurm, F. M. Balancing GFP reporter plasmid quantity in large-scale transient transfections for recombinant anti-human Rhesus-D IgG1 synthesis. Biotechnol. Bioeng. 2002, 79 (6), 595-601.
15. Hunt, L.;Batard, P.; Jordan, M.; Wurm, F. M. Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an example. Biotechnol. Bioeng. 2002, 77 (5), 528-537.
16. Girard, P.; Jordan, M.; Tsao, M.; Wurm, F. M. Small-scale bioreactor system for process development and optimization. 2001, 7 (2), 117-119.
17. Miescher, S.; Zahn-Zabal, M.; De Jesus, M.; Moudry, R.; Fisch, I.; Vogel, M.; Kobr, M.; Imboden, M. A.; Kragten, E.; Bichler, J.; Mermod, N.; Stadler, B. M.; Amstutz, H.; Wurm, F. CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. Br. J. Haematol. 2000, 111 (1), 157-166.
18. Bentley, K. J.; Gewert, R.; Harris, W. J. Differential efficiency of expression of humanized antibodies in transient transfected mammalian cells. Hybridoma 1998, 17 (6), 559-567.
19. Dul, J. L.; Argon, Y. A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion. Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (20), 8135-8139.
20. Pachlopnik, J. M.; Horn, M. P.; Fux, M.; Dahinden, M.; Mandallaz, M.; Schneeberger, D.; Baldi, L.; Vogel, M.; Stadler, B. M.; Miescher, S. M. Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J. Autoimmun. 2004, 22 (1), 43-51.
21. Fuchs, M.; Muller, T.; Lerch, M. M.; Ullrich, A. Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J. Biol. Chem. 1996, 271 (28), 16712-16719.
22. Vogt, L.; Schrimpf, S. P.; Meskenaite, V.; Frischknecht, R.; Kinter, J.; Leone, D. P.; Ziegler, U.; Sonderegger, P. Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain. Mol. Cell Neurosci. 2001, 17 (1), 151-166.
23. Welt, S.; Ritter, G.; Williams, C., Jr.; Cohen, L. S.; John, M.; Jungbluth, A.; Richards, E. A.; Old, L. J.; Kemeny, N. E. Phase I study of anticolon cancer humanized antibody A33. Clin. Cancer Res. 2003, 9 (4), 1338-1346.
24. Meier, P.; Genoud, N.; Prinz, M.; Maissen, M.; Rulicke, T.; Zurbriggen, A.; Raeber, A. J.; Aguzzi, A. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 2003, 113 (1), 49-60.
25. Saverino, D.; Ghiotto, F.; Merlo, A.; Bruno, S.; Battini, L.; Occhino, M.; Maffei, M.; Tenca, C.; Pileri, S.; Baldi, L.; Fabbi, M.; Bachi, A.; De Santanna, A. Grossi, C. E.; Ciccone, E. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8(+) T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 2004, 172 (9), 5629-5637.
26. Geisse, S.; Kocher, H. P. Protein expression in mammalian and insect cell systems. Methods Enzymol. 1999, 306, p 19-42.
27. Graham, F. L.; van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52 (2), 456-467.
28. Jordan, M.; Schallhorn, A.; Wurm, F. M. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 1996, 24 (4), 596-601.
29. Lindell, J.; Girard, P.; Muller, N.; Jordan, M.; Wurm, F. Calfection: a novel gene transfer method for suspension cells. Biochim. Biophys. Acta 2004, 1676 (2), 155-161.
30. Parham, J. H.; Kost, T.; Hutchins, J. T. Effect of pCIneo and pCEP4 expression vectors on transient and stable protein production in human and simian cell lines. Cytotechnology 2001, 35, 181-187.
31. Ambinder, R. F.; Mullen, M. A.; Chang, Y. N.; Hayward, G. S.; Hayward, S. D. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 1991, 65 (3), 1466-1478.
32. Reisman, D.; Sugden, B. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell Biol. 1986, 6 (11), 3838-3846.
33. Swaroop, M.; Moussalli, M.; Pipe, S. W.; Kaufman, R. J. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J. Biol. Chem. 1997, 272 (39), 24121-24124.